| 1 |
Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation |
|
|
| Abdullah A. Alqarni, Oliver J. Brand, Alice Pasini, Mushabbab Alahmari, Abdulrhman Alghamdi, Linhua Pang |
|
| Respiratory Research. 2022; 23(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension |
|
|
| Asma Mohammadi, Wanessa F Matos, Cesar Intriago, Keval Thakkar, Nasrin Jahan, Heeya Shah, Rifath I Nishu, Sima Marzban |
|
| Cureus. 2021; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
The changing face of pulmonary hypertension diagnosis: a historical perspective on the influence of diagnostics and biomarkers |
|
|
| Jenny L. Hewes, Ji Young Lee, Karen A. Fagan, Natalie N. Bauer |
|
| Pulmonary Circulation. 2020; 10(1): 2045894019 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Nitric Oxide Stroke Volume Index as a New Hemodynamic Prognostic Parameter for Patients with Pulmonary Arterial Hypertension |
|
|
| Karolina Baranska-Pawelczak, Celina Wojciechowska, Mariusz Opara, Wojciech Jachec |
|
| Journal of Clinical Medicine. 2020; 9(9): 2939 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Clinical update on pulmonary hypertension |
|
|
| Salim Yaghi, Anastasia Novikov, Theo Trandafirescu |
|
| Journal of Investigative Medicine. 2020; 68(4): 821 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension |
|
|
| Jessica Y. Hsu, Jennifer L. Major, Andrew S. Riching, Rwik Sen, Julie Pires da Silva, Rushita A. Bagchi |
|
| Biochemistry and Cell Biology. 2020; 98(6): 631 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Hypoxia-induced Pulmonary Hypertension in Different Mouse Strains: Relation to Transcriptome |
|
|
| Kahori T. Ikeda, Philip T. Hale, Michael W. Pauciulo, Nupur Dasgupta, Patricia A. Pastura, Timothy D. Le Cras, Manoj K. Pandey, William C. Nichols |
|
| American Journal of Respiratory Cell and Molecular Biology. 2019; 60(1): 106 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Pharmacological Management of Pulmonary Arterial Hypertension |
|
|
| Beatrice Adams,Kevin T. Ferguson |
|
| AACN Advanced Critical Care. 2014; 25(4): 309 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
The role of endothelin-1 in pulmonary arterial hypertension |
|
|
| Adrian H. Chester,Magdi H. Yacoub |
|
| Global Cardiology Science and Practice. 2014; 2014(2): 29 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Increased Reactive Oxygen Species, Metabolic Maladaptation, and Autophagy Contribute to Pulmonary Arterial Hypertension–Induced Ventricular Hypertrophy and Diastolic Heart Failure |
|
|
| Dhawjbahadur K. Rawat, Abdallah Alzoubi, Rakhee Gupte, Sukrutha Chettimada, Makino Watanabe, Andrea G. Kahn, Takao Okada, Ivan F. McMurtry, Sachin A. Gupte |
|
| Hypertension. 2014; 64(6): 1266 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Impact of pulmonary hypertension on tricuspid valve function |
|
|
| Casa, L.D.C. and Dolensky, J.R. and Spinner, E.M. and Veledar, E. and Lerakis, S. and Yoganathan, A.P. |
|
| Annals of Biomedical Engineering. 2013; 41(4): 709-724 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Impact of Pulmonary Hypertension on Tricuspid Valve Function |
|
|
| Lauren D. C. Casa,Joseph R. Dolensky,Erin M. Spinner,Emir Veledar,Stamatios Lerakis,Ajit P. Yoganathan |
|
| Annals of Biomedical Engineering. 2013; 41(4): 709 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Factors associated with adherence to phosphodiesterase type 5 inhibitors for the treatment of pulmonary arterial hypertension |
|
|
| Aaron Waxman,Shih-Yin Chen,Luke Boulanger,Jay A. Watson,Gil Golden |
|
| Journal of Medical Economics. 2013; 16(2): 298 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 14 |
Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension |
|
|
| Savai, R. and Pullamsetti, S.S. and Kolbe, J. and Bieniek, E. and Voswinckel, R. and Fink, L. and Scheed, A. and Ritter, C. and Dahal, B.K. and Vater, A. and Klussmann, S. and Ghofrani, H.A. and Weissmann, N. and Klepetko, W. and Banat, G.A. and Seeger, W. and Grimminger, F. and Schermuly, R.T. |
|
| American Journal of Respiratory and Critical Care Medicine. 2012; 186(9): 897-908 |
|
| [Pubmed] [Google Scholar] |
|
| 15 |
Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension |
|
|
| Rajkumar Savai,Soni S. Pullamsetti,Julia Kolbe,Ewa Bieniek,Robert Voswinckel,Ludger Fink,Axel Scheed,Christin Ritter,Bhola K. Dahal,Axel Vater,Sven Klussmann,Hossein A. Ghofrani,Norbert Weissmann,Walter Klepetko,Gamal A. Banat,Werner Seeger,Friedrich Grimminger,Ralph T. Schermuly |
|
| American Journal of Respiratory and Critical Care Medicine. 2012; 186(9): 897 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 16 |
Pulmonary Arterial Hypertension |
|
|
| Allinson, R. |
|
| Pharmacy Times. 2011; 77(4) |
|
| [Pubmed] [Google Scholar] |
|
